July 29, 2014     Japanese 
  JCN 
	  Network - Home
JCN Newswire
  Home  |  Companies  | Annual Reports  |  CSR  | News Alerts     
 
Share:
Shin Nippon Biomedical Laboratories, Takeda Pharmaceutical Successfully Complete Joint Research on Cynomolgus Monkey
 

Tokyo, June 26, 2006 (JCN) - Shin Nippon Biomedical Laboratories (SNBL) announced on June 26 that it has completed a joint research project with Takeda Pharmaceutical.

Since 2002, the two companies have collaborated in the search and analysis of organ-specific virulence-associated genes of cynomolgus ("crab-eating") monkeys. The aim of this collaboration is to develop an effective tool for analyzing and estimating the toxicity of drug candidates.

Through the four-year collaboration, the partners have analyzed genes expressed in the six main organs of cynomolgus monkeys and established a database that covers the entire genome sequences of cynomolgus monkey.

Further, they have created a customized DNA microarray that mounts representative sequences from 15,000 genes. Subsequently, they have confirmed that the customized DNA microarray can be used to evaluate toxicity in primates. Further, they have developed a gene expression database for 27 organs used in toxicity analysis.

Details of the joint research were presented at the 46th Annual Meeting of the Society of Toxicology and will be presented at the 33rd Annual Meeting of the Japanese Society of Toxicology, to be held in Nagoya in July.

Going forward, SNBL plans to proceed with research and aims to develop an innovative tool for toxicity analysis of drug candidates.

By Aki Tsukioka Contributor

Copyright © 2014 JCN. All rights reserved. A division of Japan Corporate News Network KK.


 Company Profile |   Print  |   Alerts
ACN Newswire

 Recent  Takeda News  
  Companies Submit Joint Application Seeking Approval for Additional Indication for Helicobacter pylori  (Aug 31, 2012)
  Takeda and Envoy Partner on Schizophrenia Research  (Oct 8, 2010)
  Terumo, Takeda to Co-promote Takeda's Ethical Narcotic Formulations  (Sept 4, 2009)
  XOMA, Takeda Expand Collaboration  (Feb 10, 2009)
  Takeda Cuts FY '08 Earnings Forecasts on Stronger Yen  (Nov 5, 2008)
  Takeda Ups Half-Year Earnings Estimates  (Oct 20, 2008)
  Takeda Established a New Company for Asian Sales & Marketing  (Sept 25, 2008)
  Takeda Established a New Company for Clinical Development in the Asia-Oceania Region  (Sept 25, 2008)
  Shionogi to Acquire U.S. Drug Maker Sciele Pharma  (Sept 1, 2008)
  Takeda Pharmaceutical Raises Earnings Forecast for FY 2008  (July 31, 2008)



 Recent  Biotech News   
Sysmex, Toppan Printing to Collaborate in Genetic Analysis Testing (June 9, 2014)
Takara Bio Submits IND Application to FDA for HF10 Anti-cancer Therapy (May 12, 2014)
Nitto Denko Anti-fibrosis Drug with Molecular Targeting DDS Completes Phase-1a Dose Escalation (Apr 24, 2014)
Kaneka, RIKEN Synthesize Bioplastic from Non-food Plant Resources
 (Apr 14, 2014)
Takara Bio Completes Enrollment for Phase I Clinical Trial in the US for HF10 Anti-Cancer Therapy (Apr 10, 2014)
Dainippon Sumitomo Pharma Establishes Anti-Cancer Drugs Sales Company in the U.S. (Oct 10, 2013)
EIZO, Stryker to Partner in Monitor Management Systems for Operating Rooms (Oct 8, 2013)
HOYA to Invest in EndoMaster, for Robotic-assisted Surgical Systems (Aug 19, 2013)
Dainippon Screen Launches High-speed Three-dimensional Cell Culture Scanner (Aug 8, 2013)
Daiichi Sankyo Expands Collaborative Drug Discovery Program to Germany, Switzerland, and Austria (Aug 1, 2013)

More Biotech news...

 Recent  Biotech News   
Sysmex, Toppan Printing to Collaborate in Genetic Analysis Testing (June 9, 2014)
Takara Bio Submits IND Application to FDA for HF10 Anti-cancer Therapy (May 12, 2014)
Nitto Denko Anti-fibrosis Drug with Molecular Targeting DDS Completes Phase-1a Dose Escalation (Apr 24, 2014)
Kaneka, RIKEN Synthesize Bioplastic from Non-food Plant Resources
 (Apr 14, 2014)
Takara Bio Completes Enrollment for Phase I Clinical Trial in the US for HF10 Anti-Cancer Therapy (Apr 10, 2014)
Dainippon Sumitomo Pharma Establishes Anti-Cancer Drugs Sales Company in the U.S. (Oct 10, 2013)
EIZO, Stryker to Partner in Monitor Management Systems for Operating Rooms (Oct 8, 2013)
HOYA to Invest in EndoMaster, for Robotic-assisted Surgical Systems (Aug 19, 2013)
Dainippon Screen Launches High-speed Three-dimensional Cell Culture Scanner (Aug 8, 2013)
Daiichi Sankyo Expands Collaborative Drug Discovery Program to Germany, Switzerland, and Austria (Aug 1, 2013)

More Biotech news...
 
CSR Report Download
Annual Reports

  More >>    
Most Popular


About JCN | Privacy Policy | Terms of Use | JCN Network (日本語)